Clinical trial
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Newly Diagnosed Glioblastoma
NCT02880410 is registered in ClinicalTrials.gov with Monteris Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Newly Diagnosed Glioblastoma
- Lead sponsor
- Monteris Medical
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- August 15, 2017
- Completion date
- September 14, 2018
- Enrollment
- 3 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.